Literature DB >> 6199071

Pre-operative carcino-embryonic antigen and survival in patients with colorectal cancer.

H Lewi, L H Blumgart, D C Carter, C R Gillis, D Hole, J G Ratcliffe, C B Wood, C S McArdle.   

Abstract

The relationship between pre-operative levels of carcino-embryonic antigen (CEA), resectability of the primary tumour, the extent of tumour spread and subsequent survival was studied in 333 patients with colorectal cancer. Twenty-five per cent of patients undergoing 'curative' resection had elevated CEA levels compared with fifty-six per cent of patients receiving palliative treatment. Twenty-five per cent of patients with Dukes B or C tumours had elevated pre-operative CEA levels compared with seventy per cent of patients with stage D disease. In patients undergoing 'curative' resection there was no correlation between pre-operative CEA levels and subsequent survival. In patients undergoing palliative resection, elevated pre-operative CEA levels were associated with poor survival. Although pre-operative levels of CEA reflect the extent of the underlying disease process, estimations of pre-operative CEA levels are of limited value in predicting patients with a poor prognosis following curative resection for colorectal carcinoma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199071     DOI: 10.1002/bjs.1800710312

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

Review 1.  Pre-operative evaluation of patients with low rectal carcinoma.

Authors:  P Durdey; N S Williams
Journal:  World J Surg       Date:  1992 May-Jun       Impact factor: 3.352

2.  [The significance of the preoperative CEA value for the prognosis of rectal cancer].

Authors:  B Mentges; R Brückner; C Weiss
Journal:  Langenbecks Arch Chir       Date:  1990

3.  Combined detection of preoperative serum CEA, CA19-9 and CA242 improve prognostic prediction of surgically treated colorectal cancer patients.

Authors:  Jingtao Wang; Xiao Wang; Fudong Yu; Jian Chen; Senlin Zhao; Dongyuan Zhang; Yang Yu; Xisheng Liu; Huamei Tang; Zhihai Peng
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Carcinoembryonic antigen level of draining venous blood as a predictor of recurrence in colorectal cancer patient.

Authors:  Soo Young Lee; Kyung Sun Min; Jung Kee Chung; In Mok Jung; Young Joon Ahn; Ki-Tae Hwang; Hye Seong Ahn; Seung Chul Heo
Journal:  J Korean Surg Soc       Date:  2011-11-25

5.  Comparison of the prognostic value of longitudinal measurements of systemic inflammation in patients undergoing curative resection of colorectal cancer.

Authors:  G J K Guthrie; C S D Roxburgh; O M Farhan-Alanie; P G Horgan; D C McMillan
Journal:  Br J Cancer       Date:  2013-06-25       Impact factor: 7.640

6.  Isolation and preliminary characterisation of cDNA clones representing mRNAs associated with tumour progression and metastasis in colorectal cancer.

Authors:  P Elvin; I B Kerr; C S McArdle; G D Birnie
Journal:  Br J Cancer       Date:  1988-01       Impact factor: 7.640

7.  The association of preoperative serum tumour markers with Dukes' stage and survival in colorectal cancer.

Authors:  G Lindmark; R Bergström; L Påhlman; B Glimelius
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

8.  Preoperative carcinoembryonic antigen is related to tumour stage and long-term survival in colorectal cancer.

Authors:  M A Chapman; D Buckley; D B Henson; N C Armitage
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

9.  The relation of ras family oncogene expression to conventional staging criteria and clinical outcome in colorectal carcinoma.

Authors:  I B Kerr; D A Spandidos; I G Finlay; F D Lee; C S McArdle
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

10.  Liver Cancer Detection by a Simple, Inexpensive and Effective Immunosensor with Zinc Oxide Nanoparticles.

Authors:  Congo Tak-Shing Ching; Nguyen van Hieu; Teng-Yun Cheng; Lin-Shien Fu; Tai-Ping Sun; Ming-Yen Liu; Su-Hua Huang; Yan-Dong Yao
Journal:  Sensors (Basel)       Date:  2015-11-20       Impact factor: 3.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.